Vitaspring Biomedical (VSBC) EBITDA (2017 - 2026)
Vitaspring Biomedical's EBITDA was -$73,355 in fiscal Q1 2027 (quarter ended Apr 30, 2026), compared with -$66,658 a year earlier.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) EBITDA (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vitaspring Biomedical's EBITDA was -$382,151 through Apr 30, 2026; for FY2026 (ended Jan 31, 2026), it was -$375,454.
- In earlier fiscal years, EBITDA was -$669,957 in FY2025, -$1.1 million in FY2024, -$4.16 million in FY2023 and $1.14 million in FY2022.
- Quarterly EBITDA has moved between -$4.16 million (fiscal Q4 2023) and $1.42 million (fiscal Q4 2022) over five years.
- Per Business Quant data, VSBC's EBITDA in the three fiscal quarters before Q1 2027 was -$78,975 (Q4 2026), -$133,244 (Q3 2026) and -$96,577 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,155.38 Bn | 1,123.96 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.38 Bn | 542.91 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 512.27 Bn | 485.38 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 365.67 Bn | 320.05 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.43 Bn | 261.42 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.34 Bn | 235.02 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 234.97 Bn | 190.37 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 193.03 Bn | 167.22 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Vitaspring Biomedical | 6.21 Mn | 6.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -73,355.00 |
| Jan 31, 2026 | -78,975.00 |
| Oct 31, 2025 | -133,244.00 |
| Jul 31, 2025 | -96,577.00 |
| Apr 30, 2025 | -66,658.00 |
| Jan 31, 2025 | -124,005.00 |
| Oct 31, 2024 | -115,438.00 |
| Jul 31, 2024 | -216,172.00 |
| Apr 30, 2024 | -214,342.00 |
| Jan 31, 2024 | -221,633.00 |
| Oct 31, 2023 | -231,214.00 |
| Jul 31, 2023 | -349,818.00 |
| Apr 30, 2023 | -300,835.00 |
| Jan 31, 2023 | -4.16 Mn |
| Oct 31, 2022 | -179,453.00 |
| Jul 31, 2022 | -170,746.00 |
| Apr 30, 2022 | 346,893.00 |
| Jan 31, 2022 | 1.42 Mn |
| Oct 31, 2021 | 141,218.00 |
| Jan 31, 2021 | -345,730.00 |
API Access
Vitaspring Biomedical EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();